These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 8791956

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series.
    Absah I, Faubion WA.
    Inflamm Bowel Dis; 2012 Aug; 18(8):1488-92. PubMed ID: 21882301
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Efficacy and safety of azathioprine maintenance therapy in a group of Crohn's disease patients in China.
    Zheng JJ, Chu XQ, Shi XH, Zhou CL, Seng BW.
    J Dig Dis; 2008 May; 9(2):84-8. PubMed ID: 18419641
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease.
    Turner D, Grossman AB, Rosh J, Kugathasan S, Gilman AR, Baldassano R, Griffiths AM.
    Am J Gastroenterol; 2007 Dec; 102(12):2804-12; quiz 2803, 2813. PubMed ID: 18042110
    [Abstract] [Full Text] [Related]

  • 29. Mild to moderate Crohn's disease: still room for step-up therapies?
    Bar-Meir S.
    Dig Dis; 2009 Dec; 27(3):347-50. PubMed ID: 19786763
    [Abstract] [Full Text] [Related]

  • 30. Review article: the evidence base for interventions used to maintain remission in Crohn's disease.
    Akobeng AK.
    Aliment Pharmacol Ther; 2008 Jan 01; 27(1):11-8. PubMed ID: 17919275
    [Abstract] [Full Text] [Related]

  • 31. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.
    D'Haens G, Baert F, van Assche G, Caenepeel P, Vergauwe P, Tuynman H, De Vos M, van Deventer S, Stitt L, Donner A, Vermeire S, Van De Mierop FJ, Coche JR, van der Woude J, Ochsenkühn T, van Bodegraven AA, Van Hootegem PP, Lambrecht GL, Mana F, Rutgeerts P, Feagan BG, Hommes D, Belgian Inflammatory Bowel Disease Research Group, North-Holland Gut Club.
    Lancet; 2008 Feb 23; 371(9613):660-667. PubMed ID: 18295023
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Long term evolution of corticodependant and corticoresistant Crohn's disease patients treated by azzathioprine].
    Karoui S, Hamrouni A, Bibani N, Serghini M, Boubaker J, Filali A.
    Tunis Med; 2011 Jul 23; 89(7):610-5. PubMed ID: 21780035
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Long-term outcome of Crohn's disease following corticosteroid-induced remission.
    Papi C, Festa V, Leandro G, Moretti A, Tanga M, Koch M, Capurso L.
    Am J Gastroenterol; 2007 Apr 23; 102(4):814-9. PubMed ID: 17222316
    [Abstract] [Full Text] [Related]

  • 37. Methotrexate and maintenance of remission in Crohn's disease.
    Fishman M.
    Can J Gastroenterol; 2001 Jul 23; 15(7):428. PubMed ID: 11493943
    [No Abstract] [Full Text] [Related]

  • 38. [Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate].
    Hafraoui S, Dewit O, Marteau P, Cosnes J, Colombel JF, Modigliani R, Cortot A, Lémann M.
    Gastroenterol Clin Biol; 2002 Jan 23; 26(1):17-22. PubMed ID: 11938035
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.